XML 15 R4.htm IDEA: XBRL DOCUMENT v3.25.1
UNAUDITED CONSOLIDATED STATEMENTS OF NET INCOME - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Revenues:    
Net revenue $ 183,788 $ 155,675
Operating cost:    
Salaries and related costs 111,249 93,731
Rent, supplies, contract labor and other 33,844 27,904
Depreciation and amortization 5,540 3,885
Provision for credit losses 1,848 1,627
Clinic closure costs - lease and other 242 127
Total operating cost 152,723 127,274
Gross profit 31,065 28,401
Corporate office costs 16,245 14,085
Gain on change in fair value of contingent earn-out consideration (4,822) (612)
Operating income 19,642 14,928
Other (expense) income    
Interest expense, debt and other (2,279) (1,968)
Interest income from investments 24 1,543
Change in revaluation of put-right liability (404) (80)
Equity in earnings of unconsolidated affiliate 393 271
Loss on sale of a partnership (123) 0
Other 75 62
Total other expense (2,314) (172)
Income before taxes 17,328 14,756
Provision for income taxes 3,860 3,139
Net income 13,468 11,617
Less: Net income attributable to non-controlling interest:    
Redeemable non-controlling interest - temporary equity (2,012) (2,227)
Non-controlling interest - permanent equity (1,557) (1,344)
Net income attributable to non-controlling interest (3,569) (3,571)
Net income attributable to USPH shareholders $ 9,899 $ 8,046
Basic earnings per share attributable to USPH shareholders (in dollars per share) $ 0.8 $ 0.46
Diluted earnings per share attributable to USPH shareholders (in dollars per share) $ 0.8 $ 0.46
Shares used in computation - basic (in shares) 15,132 15,017
Shares used in computation - diluted (in shares) 15,132 15,017
Dividends declared per common share (in dollars per share) $ 0.45 $ 0.44
Net Patient Revenue [Member]    
Revenues:    
Net revenue $ 152,547 $ 131,075
Other Revenue [Member]    
Revenues:    
Net revenue $ 31,241 $ 24,600